Enzo Biochem, Inc. Quarterly report pursuant to Section 13 or 15(d)

Accrued Liabilities and Other Current Liabilities

3 Months Ended

Oct. 31, 2011

Note 9 – Accrued Liabilities and Other Current Liabilities

Accrued liabilities consist of the following as of:


	October 31, 2011		July 31, 2011

Legal	$	1,131	$	610
Payroll, benefits, and commissions		4,448		4,286
Research and development		709		709
Professional fees		981		782
Other		2,118		1,801

	$	9,387	$	8,188


Other current liabilities consist of the following as of:



	October 31, 2011		July 31, 2011

Liability for purchase price consideration (see Note 13)		1,150		1,150
Deferred revenue		347		396
Other		153		137

	$	1,650	$	1,683